|
Volumn 43, Issue 4, 2012, Pages 1131-1133
|
Hospitalization costs for acute ischemic stroke patients treated with intravenous thrombolysis in the United States are substantially higher than medicare payments
|
Author keywords
acute stroke; stroke care; thrombolysis; tissue type plasminogen activator
|
Indexed keywords
FIBRINOLYTIC AGENT;
ADULT;
AGED;
ARTICLE;
BLOOD CLOT LYSIS;
BRAIN HEMORRHAGE;
BRAIN ISCHEMIA;
COMPLICATION;
DEMOGRAPHY;
FEMALE;
HEALTH CARE COST;
HOSPITALIZATION;
HUMAN;
LENGTH OF STAY;
MAJOR CLINICAL STUDY;
MALE;
MEDICARE;
MORTALITY;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
UNITED STATES;
UNSPECIFIED SIDE EFFECT;
AGED;
AGED, 80 AND OVER;
BRAIN ISCHEMIA;
COSTS AND COST ANALYSIS;
FEMALE;
HOSPITALIZATION;
HUMANS;
MALE;
MEDICARE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
STROKE;
THROMBOLYTIC THERAPY;
UNITED STATES;
|
EID: 84859422639
PISSN: 00392499
EISSN: 15244628
Source Type: Journal
DOI: 10.1161/STROKEAHA.111.636142 Document Type: Article |
Times cited : (29)
|
References (7)
|